Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people: systematic review and economic evaluation

Duarte, A; Mebrahtu, T; Goncalves, PS; Harden, M; Murphy, R; Palmer, S; Woolacott, N; Rodgers, M; Rothery, C

Rodgers, M (reprint author), Univ York, Ctr Reviews & Disseminat, York, N Yorkshire, England.

HEALTH TECHNOLOGY ASSESSMENT, 2017; 21 (64): 1

Abstract

Background: Psoriasis is a chronic inflammatory disease that predominantly affects the skin. Adalimumab (HUMIRA (R), AbbVie, Maidenhead, UK), etanerce......

Full Text Link